Hoos Axel 4
4 · TCR2 THERAPEUTICS INC. · Filed Apr 15, 2020
Insider Transaction Report
Form 4
Hoos Axel
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-04-13+9,596→ 9,596 totalExercise: $10.42Exp: 2030-04-12→ Common Stock (9,596 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on April 13, 2021, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.